These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Effective reduction of brown fat FDG uptake by controlling environmental temperature prior to PET scan: an expanded case series. Garcia C; Bandaru V; Van Nostrand D; Chennupati S; Atkins F; Acio E; Kulkarni K; Majd M Mol Imaging Biol; 2010 Dec; 12(6):652-6. PubMed ID: 20237858 [TBL] [Abstract][Full Text] [Related]
24. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results. Heusch P; Buchbender C; Köhler J; Nensa F; Beiderwellen K; Kühl H; Lanzman RS; Wittsack HJ; Gomez B; Gauler T; Schuler M; Forsting M; Bockisch A; Antoch G; Heusner TA Rofo; 2013 Nov; 185(11):1056-62. PubMed ID: 23860802 [TBL] [Abstract][Full Text] [Related]
25. Effect of hepatic steatosis on liver FDG uptake measured in mean standard uptake values. Abele JT; Fung CI Radiology; 2010 Mar; 254(3):917-24. PubMed ID: 20177102 [TBL] [Abstract][Full Text] [Related]
26. Detection of gastric cancer using 18F-FLT PET: comparison with 18F-FDG PET. Kameyama R; Yamamoto Y; Izuishi K; Takebayashi R; Hagiike M; Murota M; Kaji M; Haba R; Nishiyama Y Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):382-8. PubMed ID: 18985344 [TBL] [Abstract][Full Text] [Related]
27. The reverse Warburg effect and 18F-FDG uptake in non-small cell lung cancer A549 in mice: a pilot study. Zhang G; Li J; Wang X; Ma Y; Yin X; Wang F; Zheng H; Duan X; Postel GC; Li XF J Nucl Med; 2015 Apr; 56(4):607-12. PubMed ID: 25722447 [TBL] [Abstract][Full Text] [Related]
29. Positron emission tomographic imaging with 11C-choline in differential diagnosis of head and neck tumors: comparison with 18F-FDG PET. Khan N; Oriuchi N; Ninomiya H; Higuchi T; Kamada H; Endo K Ann Nucl Med; 2004 Jul; 18(5):409-17. PubMed ID: 15462403 [TBL] [Abstract][Full Text] [Related]
30. Grading of brain glioma with 1-11C-acetate PET: comparison with 18F-FDG PET. Tsuchida T; Takeuchi H; Okazawa H; Tsujikawa T; Fujibayashi Y Nucl Med Biol; 2008 Feb; 35(2):171-6. PubMed ID: 18312826 [TBL] [Abstract][Full Text] [Related]
31. Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature. Guan ZW; Xu BX; Wang RM; Sun L; Tian JH Hell J Nucl Med; 2013; 16(2):97-102. PubMed ID: 23687644 [TBL] [Abstract][Full Text] [Related]
32. Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings. Kim SC; Machac J; Krynyckyi BR; Knesaurek K; Krellenstein D; Schultz B; Gribetz A; DePalo L; Teirstein A; Kim CK Ann Nucl Med; 2008 Apr; 22(3):165-70. PubMed ID: 18498030 [TBL] [Abstract][Full Text] [Related]
33. Relationships between oxygen and glucose metabolism in human liver tumours: positron emission tomography using (15)O and (18)F-deoxyglucose. Fukuda K; Taniguchi H; Koh T; Kunishima S; Yamagishi H Nucl Med Commun; 2004 Jun; 25(6):577-83. PubMed ID: 15167517 [TBL] [Abstract][Full Text] [Related]
34. Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in predicting treatment response in unresectable hepatocellular carcinoma patients treated with external beam radiotherapy. Kim JW; Seong J; Yun M; Lee IJ; Yoon HI; Cho HJ; Han KH Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1172-8. PubMed ID: 21570203 [TBL] [Abstract][Full Text] [Related]
35. Semiquantitative Analysis of the Biodistribution of the Combined ¹⁸F-NaF and ¹⁸F-FDG Administration for PET/CT Imaging. Minamimoto R; Mosci C; Jamali M; Barkhodari A; Habte F; Jackson T; Mittra E; Gambhir SS; Iagaru A J Nucl Med; 2015 May; 56(5):688-94. PubMed ID: 25840978 [TBL] [Abstract][Full Text] [Related]
36. Validation for performing ¹¹C-methionine and ¹⁸F-FDG-PET studies on the same day. Mitsumoto T; Kubota K; Sato T; Morooka M; Minamimoto R; Shimbo T; Muramatsu Y; Sasaki T; Ito K; Fukushi M Nucl Med Commun; 2012 Mar; 33(3):297-304. PubMed ID: 22107999 [TBL] [Abstract][Full Text] [Related]
37. Evaluating FDG uptake changes between pre and post therapy respiratory gated PET scans. Aristophanous M; Yong Y; Yap JT; Killoran JH; Allen AM; Berbeco RI; Chen AB Radiother Oncol; 2012 Mar; 102(3):377-82. PubMed ID: 22265731 [TBL] [Abstract][Full Text] [Related]
38. Posttreatment FDG-PET uptake in the supraglottic and glottic larynx correlates with decreased quality of life after chemoradiotherapy. Dornfeld K; Hopkins S; Simmons J; Spitz DR; Menda Y; Graham M; Smith R; Funk G; Karnell L; Karnell M; Dornfeld M; Yao M; Buatti J Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):386-92. PubMed ID: 18164842 [TBL] [Abstract][Full Text] [Related]
39. Quantitative assessment of truncal FDG-PET examination with postinjection transmission scan--comparison with preinjection transmission scan. Tsuchida T; Sugimoto K; Nishizawa S; Yonekura Y; Itoh H Ann Nucl Med; 2004 Jun; 18(4):333-6. PubMed ID: 15359927 [TBL] [Abstract][Full Text] [Related]
40. Comparison of different SUV-based methods for monitoring cytotoxic therapy with FDG PET. Stahl A; Ott K; Schwaiger M; Weber WA Eur J Nucl Med Mol Imaging; 2004 Nov; 31(11):1471-8. PubMed ID: 15257418 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]